Transfection Reagents and Equipment Global Market Report 2024: Market Set to Soar with Emerging Trends and Growing Healthcare Expenditures - Long-term Forecasts to 2028 and 2033

Dublin, Jan. 25, 2024 (GLOBE NEWSWIRE) -- The "Transfection Reagents and Equipment Global Market Report 2024" report has been added to's offering.

The global market for transfection reagents and equipment is undergoing significant growth, driven by innovations and rising healthcare investments. A comprehensive transfection reagents and equipment market research report, which covers a detailed analysis of current and future industry trends, has been added to our collection of market research publications.

Market Overview

The transfection reagents and equipment market, pivotal to breakthroughs in gene and cancer therapy research, has reported a notable surge in market value. As the use of these essential tools in genetic research, gene therapy, and biopharmaceutical development grows, supported by rising global healthcare expenditures, this sector is seeing an influx of advanced product developments and strategic industry collaborations.

The detailed market report encapsulates the scope and scale of the transfection reagents and equipment industry on a global platform. Key insights into the expanding application areas, increasing demand for specialized reagents, and the strategic moves by industry leaders fueling the market landscape are comprehensively discussed.

Emerging Trends

Bolstered by the urgent need to address the alarming rate of cancer prevalence worldwide, the transfection reagents and equipment market is experiencing a considerable demand for innovative products and solutions. Developments in mRNA vaccine technology and gene editing, as well as the rise of cell-based therapies, are among the trends propelling market growth rates to unprecedented highs.

Furthermore, the incorporation of automation and high-throughput systems signifies a significant trend that is reshaping the sector, leading to advancements in research methodologies and the rapid acceleration of novel therapeutic developments.

Regional Insights

North America currently dominates the transfection reagents and equipment market, but the Asia-Pacific region is catching up rapidly, showcasing the fastest growth rates. This can be attributed to the increasing emphasis on research and development activities, augmented by substantial healthcare investments across emerging economies.

Key Market Segments

The report segments the global market into various categories, covering instrumentation and reagent kits applicable to different organisms and end-user applications. The role of key market players and their contributions across diverse segments such as academia, biopharma, and clinical settings are analyzed to give a nuanced view of this thriving market.

  • Biomedical Research Advancements: Driving factor for the growth of the transfection reagents and equipment market.
  • Genetic Engineering Progress: Significant impact on the development of new transfection solutions.
  • Global Collaborations: Enhanced by corporate partnerships leading to innovative product developments.

The transfection reagents and equipment market research report provides an in-depth assessment of the industry's current state and highlights the potential growth opportunities with a focus on future market conditions. The report offers strategic analysis, trends, and revenue forecasts, making it a valuable resource for stakeholders, investors, and industry participants looking to understand and capitalize on the market's trajectories.

A selection of companies mentioned in this report includes

  • Thermo Fisher Scientific Inc.
  • Promega Corporation
  • Qiagen N.V.
  • Bio-Rad Laboratories Inc.
  • Maxcyte Inc.
  • Lonza Group Ltd.
  • Merck KGaA
  • Mirus Bio LLC
  • OriGene Technologies Inc.
  • PromoCell GmbH
  • PerkinElmer Inc.
  • Agilent Technologies Inc.
  • Altogen Biosystems
  • Applied Biological Materials Inc.
  • Bex Co. Ltd.
  • Sartorius AG
  • Takara Bio Inc.
  • Tecan Trading AG
  • Polyplus-transfection SA
  • Sigma-Aldrich Corporation
  • Hoffmann-La Roche Ltd.
  • Transfection Technologies Inc.
  • Viromer
  • ABM Inc.
  • Bio-Techne Corporation
  • Biotium Inc.
  • Cell Applications Inc.
  • chemicell GmbH
  • Clontech Laboratories Inc.
  • Genlantis
  • Inovio Pharmaceuticals Inc.
  • Biontex Laboratories GmbH
  • Boca Scientific Inc.
  • Jena Bioscience GmbH

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


Contact Data